Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

Abstract

Thirty-four normocalcaemic women with multiple osteolytic bone metastases from breast cancer were randomly allocated to treatment with disodium dichloromethylene diphosphonate (Cl2MDP) 1600 mg/day orally (17) or placebo (17) for 3-9 months. Fasting urinary hydroxyproline/creatinine and calcium/creatinine ratios declined in the Cl2MDP group but not in the placebo group. Four patients in the placebo group died from hypercalcaemia. New bone metastases were more common in patients on placebo and these patients also required more analgesic drugs than those on Cl2MDP. Cl2MDP seemed to reduce bone pain and bone resorption and prevent the development of hypercalcaemia caused by osteolytic metastases. The formation of new bone metastases and the growth of old ones seemed to be retarded by Cl2MDP.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(83)92755-1

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Cited by

See all 209

Metadata

Authors
Elomaa, I., Blomqvist, C., Gröhn, P., Porkka, L., Kairento, A.-L., Selander, K., Lamberg-Allardt, C., & Holmström, T.
Affiliations
University of Helsinki (FI)
Venue
The Lancet
Publisher
Elsevier BV
Published
1983-01
Volume
321
Issue
8317
Pages
146-149
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W1965682822
Cited by
209
References
24
Citations by year
2020: 3 · 2019: 2 · 2017: 2 · 2016: 2 · 2013: 2 · 2012: 2
FWCI
5.91
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Health Sciences › Medicine › Surgery › Management of metastatic bone disease
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
bisphosphonates, osteolytic bone metastasis, breast cancer, hypercalcemia, bone resorption, urinary hydroxyproline, bone pain, analgesic requirement
MeSH terms
Adult, Aged, Analgesics, Antineoplastic Agents, Bone Neoplasms, Bone Resorption, Breast Neoplasms, Clinical Trials as Topic, Clodronic Acid, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hydrocarbons, Chlorinated, Methylene Chloride, Middle Aged, Osteolysis, Random Allocation, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. https://app.cochat.ai/papers/10.1016/s0140-6736(83)92755-1
The paper
Elomaa, I., Blomqvist, C., Gröhn, P., Porkka, L., Kairento, A.-L., Selander, K., Lamberg-Allardt, C., & Holmström, T. (1983). Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. The Lancet. https://doi.org/10.1016/s0140-6736(83)92755-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.